InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: namtae post# 202463

Monday, 05/30/2016 7:32:22 AM

Monday, May 30, 2016 7:32:22 AM

Post# of 399423
Amazing how the BS I've been hearing since the .06's never shows up with 2 seconds of DD.

Like how there is "supposed" insider selling going on YET NO SEC FILINGS. WHOOPSY

Years??? Try on or before July 14.

Stories??? TRY FACTS they actually are what counts in life.

Elite Announces U.S. FDA Priority Review Designation For SequestOx™ NDA
SequestOx™ NDA Submission Accepted for Review


http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=80708&BzID=2258&t=1948&g=939&Nav=0&LangID=1&s=0

NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM (ELI-200), Elite's lead opioid abuse-deterrent candidate for the management of moderate to severe pain where the use of an opioid analgesic is appropriate, has been accepted and granted priority review by the United States Food and Drug Administration ("FDA"). The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016.


Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News